Chili Compound Capsaicin Reduces Prostate Enlargement in Insulin Resistant Rats

Insulin Resistance (IR) is a metabolic condition often characterized by elevated glucose levels and hyperinsulinemia (high insulin in the blood). Critically, these elevated insulin levels associated with IR are known to contribute to prostate enlargement, a precursor to or symptom of Benign Prostatic Hyperplasia (BPH). Despite this known link, the potential for natural compounds to intervene in this specific pathway remains underexplored. This study addresses this gap by investigating the therapeutic effects of capsaicin on IR-induced prostatic hyperplasia.

Capsaicin administration significantly improved metabolic markers, leading to an approximate 25% reduction in fasting blood glucose and a 30% reduction in insulin levels compared to untreated IR controls (p<0.05 for both). Furthermore, the treatment resulted in a substantial 20% decrease in prostate weight and mitigated adverse histopathological alterations within the prostate tissue. A key mechanistic finding was the 2-fold downregulation of IGF-1 (Insulin-like Growth Factor 1) expression, a protein crucial for cellular proliferation and differentiation, suggesting its role in reversing prostate hyperplasia. Capsaicin treatment effectively reversed both the metabolic dysregulation and the prostate enlargement induced by insulin resistance in the rat model, demonstrating significant therapeutic potential.